You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Routine second fine-needle aspiration to assess thyroid nodules not required in many cases

By Dermot - 24th Oct 2019 | 10 views

With well-targeted fine-needle aspiration (FNA) in thyroid nodules, there is a low rate of false-negatives and thus a routine second FNA is not required in these cases, according to a research study carried out by researchers at Beaumont Hospital, Dublin, and presented at the Irish Endocrine Society Annual (IES) meeting in Galway.

There remains concern that FNA can result in up to 6 per cent of false-negatives in some series when it is used to assess thyroid nodules. It is the preferred method for assessing the nodules.

This study aimed to “investigate the malignancy rate in nodules which were initially classified as benign”. It also aimed to examine the distribution of cytological categories in a large group of patients.

Researchers examined 719 nodules in 714 patients, retrospectively, between 2013 and 2017. Nodules were classified cytologically as per BTA guidelines, and all FNAs were carried out under US guidance. A total of 604, or 84.5 per cent, of the patients were female, and 110 were male.

Some 53 per cent of the nodules were either followed-up by ultrasonography or repeat FNA. The remaining nodules were followed-up clinically. Decisions regarding nodule follow-ups were made at a multidisciplinary meeting.

Some 558 of the nodules were classified as benign (77.6 per cent); 82 were thy1 (11.1 per cent), 52 were thy3 (7.2 per cent), six were thy4 (0.8 per cent), and 15 were thy5 (2 per cent).

Five of the thy2 nodules were subsequently diagnosed with thyroid cancer. One of these had low initial cellularity, one was a co-incidental microcarcinoma in a celluloid nodule, and one was a cystic papillary carcinoma. All five went into remission following treatment.

The research was carried out by the departments of endocrinology, histopathology, surgery and radiology at Beaumont Hospital, Dublin.

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]